Julio Enrique Serrano Noguès

Director/Board Member at INBEST PRIME II INMUEBLES SOCIMI, S.A.

Finance

Consumer Services

Health Technology

Profile

Julio Enrique Serrano Noguès is currently the Chief Executive Officer at Palbox Holding Sl and Director at Curapath & Expansion of Drug Delivery Capabilities & Services.
He is also a Director at Inbest Prime II Inmuebles SOCIMI SA and Inbest Prime III Inmuebles SOCIMI SA. Mr. Serrano Noguès completed his undergraduate degree at the University of Valencia.

Julio Enrique Serrano Noguès active positions

Companies	Position	Start
INBEST PRIME II INMUEBLES SOCIMI, S.A.	Director/Board Member	2019-05-12
INBEST PRIME III INMUEBLES SOCIMI, S.A.	Director/Board Member	2019-05-12
Palbox Holding Sl	Chief Executive Officer	-
Curapath & Expansion of Drug Delivery Capabilities & Services Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021.	Director/Board Member	-

All active positions of Julio Enrique Serrano Noguès

Training of Julio Enrique Serrano Noguès

University of Valencia

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Julio Enrique Serrano Noguès's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
INBEST PRIME II INMUEBLES SOCIMI, S.A.	Finance
INBEST PRIME III INMUEBLES SOCIMI, S.A.	Finance

Private companies	2
Palbox Holding Sl
Curapath & Expansion of Drug Delivery Capabilities & Services Curapath & Expansion of Drug Delivery Capabilities & Services BiotechnologyHealth Technology Curapath & Expansion of Drug Delivery Capabilities & Services is a GMP-grade manufacturer of polyamino-acid (PAA) based nanoparticle encapsulation technology for advanced drug delivery applications. The company is based in Valencia, Spain. The Spanish company offers contract development and manufacturing services, including preclinical development, analytical characterization, technology transfer, GMP manufacturing, and fill/finish services. The company was founded by Benjumea Isabela Del Alcazar, Maria Jesus VicentDocon. Robert Shaw has been the CEO of the company since 2021.	Health Technology